8 commercial payer policies list J9226. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
8 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J9226 |
|---|---|---|
| Benign Prostatic Hyperplasia | Feb 8, 2024 | Covered |
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy |
|---|
| Effective |
|---|
| Status of J9226 |
|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
|---|
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J9226 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |